A new posthoc analysis of data from the Valsartan Heart Failure Trial (Val-HeFT) has confirmed that atrial fibrillation (AF) is independently associated with an increased risk of all-cause mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback